Stock Analysis of Gamida Cell Ltd (GMDA) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code GMDA
Close 0.0184
Change -0.0143 / 43.73 %
Volume 595822
Vol Change -21538.56 K / 97.31 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Gamida Cell Ltd
PE (TTM)

-7.55

Very Poor
Price / Book

-46.01

Very Poor
Price / Sales

266.54

Very Poor
Piotroski F Score

3.0

Not Good
Market Cap

2440.56 K

Enterprise Value

36702.56 K

ROA (TTM)

-56.01

Very Poor
ROE (TTM)

0

Poor
Net Margin (TTM)

-3531.17

Very Poor
Revenue

%

673000
Net Profit

50.15 %

-76951.00 K
Debt to Equity

-27.40

Very Poor
Altman Z Score

-8.72

Very Poor
Quick Ratio

2.09

Good
Cash Ratio

1.85

Indecisive


Highs/Lows of Gamida Cell Ltd
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.0327 43.73 % 1.74 % 0.0190.015526-Apr-2426-Apr-24
Two Week0.0327 43.73 % 2.54 % 0.0190.015526-Apr-2426-Apr-24
One Month0.343 94.64 % 6.94 % 0.07650.015527-Mar-2426-Apr-24
Three Month0.3643 94.95 % 6.77 % 0.4870.015529-Jan-2426-Apr-24
Six Months0.77 97.61 % 16.82 % 0.860.015506-Nov-2326-Apr-24
One year1.54 98.81 % 26.72 % 2.510.015505-Jun-2326-Apr-24
Two year2.69 99.32 % 36.16 % 3.380.015519-Aug-2226-Apr-24
Five year8.65 99.79 % 87.03 % 2.510.015505-Jun-2326-Apr-24


Technical View of Gamida Cell Ltd
RSI

21.59

Mild Bullish
MACD

-0.090

Bearish
ADX

31.10

Bearish
Super Trend

0.131

Strong Bearish
Williams %R

-99.28

Mild Bullish
CCI

-92.97

Mild Bullish


EMA 5

0.0440

Strong Bearish
EMA 15

0.147

Strong Bearish
EMA 50

0.279

Strong Bearish
EMA 100

0.407

Strong Bearish
SMA 100

0.319

Mild Bearish
SMA 200

0.750

Strong Bearish
SMA 5 / 20

0.0350 / 0.228

Strong Bearish
SMA 15 / 50

0.194 / 0.315

Strong Bearish
SMA 50 / 200

0.315 / 0.750

Mild Bearish




Charts of Gamida Cell Ltd


Returns of Gamida Cell Ltd with Peers
Period / StockGMDASQLISPCGLMD
1 Week-43.73%-39.79%10.35%1.68%
1 Mth-94.64%-63.17%-13.84%9.93%
3 Mth-94.95%1966.74%-48.25%5.09%
6mth-97.61%1608.28%-57.17%-0.516%
1 Year-98.81%1295.16%-80.44%-91.35%
2 Year-99.32%75.04%-90.63%-95.38%
5 Years-99.79%---99.61%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Gamida Cell Ltd with Peers
Ratio / StockGMDASQLISPCGLMD
PE-7.55-8.53-0.193-0.242
P/B-46.0117.150.1810.131
ROA-56.01-98.33-69.43-44.94
ROE0-201.22-94.14-53.90
Debt To Equity-27.4000.01720.0030
Revenue673000
% 		0
100.00 % 		9928.18 K
4.56 % 		0
%
Net Income-76951.00 K
50.15 % 		-5622.16 K
37.30 % 		-11099.49 K
8.33 % 		-7535.00 K
57.82 %


Technicals of Gamida Cell Ltd with Peers
Technical / StockGMDASQLISPCGLMD-
ADX31.1024.5940.0715.86
CMF-0.264-0.291-0.2930.345
MFI29.3619.1660.2782.18
RSI21.5929.8346.8954.59
MACD Abv SignalFalseFalseFalseFalse
Price Above 50 MAFalseFalseFalseTrue-
Price Above 200 MAFalseTrueFalseFalse-


About : Gamida Cell Ltd

Address : 5 Nahum Heftsadie Street, Jerusalem, Israel, 91340
Tel : 972 2 659 5666
URL : https://www.gamida-cell.com
Code : GMDA, ISIN : IL0011552663, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 26_Oct_2018
Employee Count : 143

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.


Note : All Data Generated at the End of Trading Hours (EOD Data)